Hua He | Coronary Artery Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hua He | Coronary Artery Disease | Best Researcher Award

Beijing Anzhen Hospital Affiliated to Capital Medical University | China

Author Profile:

Scopus

Orcid

🩺 DR. HUA HE – A PIONEERING HEART SPECIALIST

👶 EARLY ACADEMIC PURSUITS

Professor Hua He began her medical journey with a strong academic foundation. In 2006, she earned her Doctor of Medicine (M.D.) in Internal Medicine from the prestigious Peking Union Medical College, one of China’s top medical institutions. During her formative academic years, she displayed exceptional interest in cardiovascular health, laying the groundwork for her future contributions to the field of cardiology.

💼 PROFESSIONAL ENDEAVORS

Currently serving as a Professor and Chief Physician at Beijing Anzhen Hospital, Capital Medical University, Professor Hua He has dedicated her career to advancing clinical practices in cardiovascular medicine. Her professional role combines teaching, clinical care, and research, making her a multi-faceted leader in internal medicine and cardiology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CORONARY ARTERY DISEASE

Professor He’s research has consistently targeted some of the most critical conditions in cardiovascular health. Her expertise spans:

  • Coronary Heart Disease

  • Arrhythmia

  • Heart Failure

More recently, her pioneering investigations into mesenchymal stem cells and their derivatives have opened promising new avenues for the treatment of ischemic heart disease. As principal investigator, she has led numerous funded research projects and experimental studies in regenerative cardiology.

📚 ACADEMIC CITES AND PUBLICATIONS

Professor Hua He has authored over 10 peer-reviewed publications, each contributing valuable insights to the cardiology research community. Her work is frequently cited by researchers and clinicians exploring new frontiers in stem cell therapy, cardiac repair, and disease modulation. These citations reflect the credibility and scientific impact of her scholarly work.

🌍 IMPACT AND INFLUENCE

Her work has had a meaningful influence not only in clinical settings, where her therapies are contributing to patient recovery and rehabilitation, but also in academic spheres, where her findings continue to shape medical discourse on cardiovascular regeneration. As a mentor and educator, she plays a vital role in nurturing the next generation of physicians and researchers.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

With a career built on innovation and compassion, Professor Hua He is establishing a legacy as one of China’s most forward-thinking medical researchers in cardiovascular treatment. Looking ahead, she is expected to:

  • Expand her research on stem-cell-derived therapies

  • Enhance collaborative international studies

  • Influence cardiac treatment protocols worldwide

Her enduring commitment to research, education, and clinical practice ensures that her contributions will resonate for generations.

📑NOTABLE PUBLICATIONS

"Association between the (neutrophil + monocyte)/albumin ratio and all-cause mortality in sepsis patients: a retrospective cohort study and predictive model establishment according to machine learning"

Authors: T., Lulu Liu; Qian Ma; Guangzan Yu; Xuhou Ji; Hua He
Journal: BMC Infectious Diseases
Year: 2025

"Association between cardiorenal syndrome and depressive symptoms among the US population: a mediation analysis via lipid indices"

Authors: Guangzan Yu; Lulu Liu; Qian Ma; Hua He
Journal: Lipids in Health and Disease
Year: 2024

"Non-linear Association of CAR with all-Cause and Cardiovascular Mortality in Coronary Heart Disease: A Retrospective Cohort Study from NHANES"

Authors: Ming Ye; Guangzan Yu; Fusheng Han; Hua He
Journal: Clinical and Applied Thrombosis/Hemostasis
Year: 2024

Xu Zhichen | Esophageal Cancer | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Xu Zhichen | Esophageal Cancer | Best Research Article Award

First Hospital of Quanzhou Affiliated to Fujian Medical University | China

Author Profile:

Scopus

👨‍⚕️ XU ZHICHEN: DEDICATED HEALER AND ESOPHAGEAL CANCER RESEARCHER

📚 EARLY ACADEMIC PURSUITS

Xu Zhichen was born in Putian, belonging to the Han ethnic group. His journey into the world of medicine began with a Bachelor's degree in Clinical Neurology from Luzhou Medical College (2005–2010). Demonstrating a strong passion for advancing cancer treatment, he pursued a Master’s degree in Radiation Oncology at Fujian Medical University (2010–2013), focusing on Radiotherapy. His formal education laid a solid foundation for a career devoted to battling cancer, particularly esophageal cancer.

🏥 PROFESSIONAL ENDEAVORS

Following his master’s program, Xu Zhichen completed standardized clinical training at Quanzhou First Hospital (2013.9–2014.9). In September 2014, he officially joined the Radiotherapy Department at the same institution, where he continues to serve with distinction as an Associate Chief Physician. His dedication and skill have earned him certifications at every level of practice, including:

  • Practicing Physician Certificate (2016)

  • Official Appointment (2018)

  • Vice Senior Certification in Radiotherapy (2024)

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ESOPHAGEAL CANCER

Dr. Xu Zhichen is a recognized specialist in esophageal cancer, with his clinical and research efforts focusing on radiotherapy advancements. His notable academic contributions include:

  • Leading one provincial and one municipal research project.

  • Publishing 1 CSCD-indexed paper, 2 SCI-indexed papers, and multiple provincial-level papers.

These publications highlight his continuous effort to innovate and improve therapeutic strategies in radiation oncology.

🌐 IMPACT AND INFLUENCE

Dr. Xu’s influence extends beyond the clinic. He is a prominent figure in academic and professional circles:

  • Selected for the "Hundred Talent Program" at Quanzhou First Hospital – a mark of distinction for emerging medical leaders.

  • Serves as a Member of the Youth Committee of the Fujian Radiation Oncology Society, where he contributes to shaping policies and mentoring young oncologists.

📊 ACADEMIC CITES AND RECOGNITION

Though still in the early stages of senior-level research contribution, Dr. Xu’s SCI and CSCD publications have gained attention in the oncology community. His work is regularly cited in Chinese medical journals focused on radiotherapy protocols and esophageal cancer treatment methodologies, underlining his growing academic footprint.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

With a decade of focused clinical experience and increasing research output, Dr. Xu Zhichen is set to become a leading voice in radiation oncology in Fujian Province and beyond. His blend of practical excellence, academic commitment, and institutional leadership signals a promising trajectory. Future expectations include:

  • Expansion into multi-institutional clinical trials on esophageal cancer.

  • Publishing in high-impact international journals.

  • Training and mentoring the next generation of radiation oncologists.

📑 NOTABLE PUBLICATIONS

"A dynamic nomogram for predicting abdominal lymph node recurrence in patients with esophageal carcinoma" 

Authors: Z., Xu, Zhichen , B., Su, Baoan , M., Lin, Mingqiang , Q., Xu, Qinghua , M., Qu, Mengke
Journal: Scientific Reports
Year: 2025